Treatment of Cheilitis Granulomatosa with Chloroquin: A case report

author

  • MA Mapar
Abstract:

Cheilitis granulomatosa is a rare disorder of unknown etiology. The condition produces chronic and persistent swelling of one or both lips. The treatment of cheilitis granulomatosa is usually ineffective. Various forms of treatment have been used with variable success. Here I report a 40-year old woman from suburbs of Ahwaz, with persistent swelling of lower lip from 8 months ago, who had not responded to several therapies. She was treated with oral chloroquin 150 mg 3 times a day and topical ointment of Zinc oxide. The swelling of her lip subsided completely after 4 weeks of treatment. In follow up at 6 months, the disease was still in remission.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Cheilitis Granulomatosa – A Rare Case Report

Cheilitis granulomatosa (CG) is a disorder affecting the orofacial region with a clinical picture of diffuse, firm, nontender swelling of the one or both the lips that may or may not occur in conjunction with gingival enlargement. As the etiology remains unknown, the treatment of CG remains challenging. Delay in diagnosis or treating CG leads to permanent induration of the lip that compromises ...

full text

Improvement of Cheilitis granulomatosa after Dental Treatment

A 38-year-old male suffered from swelling of the lower lip for 3 months. Neither facial nerve palsy nor fissuring of the tongue was present. Histological examination of a biopsy taken from the lower lip revealed non-caseous epithelioid cell granulomas, suggestive of cheilitis granulomatosa. Patch testing revealed positive reactions to mercury chloride and amalgam. His symptoms markedly improved...

full text

Cheilitis granulomatosa associated with lupus erythematosus discoid and treated with methotrexate: report of a case*

We present the rare case of a 47-year-old patient, suffering from cheilitis granulomatosa and lupus erythematosus discoid: this association is really exceptional because only once reported in English literature. In addition, the treatment of cheilitis granulomatosa is a challenge for the dermatologist: the gold standard, represented by steroids, is in fact designed as a short-time option. Our r...

full text

CASE REPORT Borderline leprosy masquerading as cheilitis granulomatosa: A case report

RAGHAVENDRA RAO*, GAGAN JOT KAUR**, ANURADHA CK RAO***, BALACHANDRAN CHANDRASHEKAR*, LAXMI RAO*** & SRIPATHI HANDATTU* *Department of Dermatology, Kasturba Medical College, Manipal University, Manipal, Karnataka 576104, India **Department of Skin & VD, Guru Govind Singh Medical College, Faridkot, Punjab, India ***Department of Pathology Kasturba Medical College, Manipal University, Manipal, Kar...

full text

Cheilitis granulomatosa associated with Melkersson-Rosenthal syndrome.

Melkersson-Rosenthal syndrome (MRS) consists of persistent or recurrent orofacial edema, relapsing facial palsy and fissured tongue. The complete triad of symptoms is uncommon, varying from 8 to 25%. The presentation of only one symptom is more common. The most frequent complaint is facial edema and enlargement of the lips. We describe a case of a 17-year-old Brazilian girl with limited edema o...

full text

Case report of cheilitis granulomatosa and joint complaints as presentation of Crohn’s disease

Cheilitis granulomatosa is characterized by granulomatous lip swelling. We report a case of a 13-year-old girl who presented with orofacial swelling and arthralgia, who eventually was diagnosed with Crohn's disease, which was successfully treated with infliximab and azathioprine combination therapy. Recurrent or persistent orofacial swelling should prompt consideration of cheilitis granulomatos...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 3  issue 2

pages  35- 38

publication date 2000-01-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023